General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(SIGNIFICANT), Pfizer(SIGNIFICANT), Affinia Therapeutics(MODEST) EQUITY INTERESTS/STOCK OPTIONS: TMAPrecision Medicine(MODEST), Bloomer Tech(NONE) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Atman Health(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Sanofi-Aventis(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Verily(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Pfizer Inc(NONE), Apple(SIGNIFICANT)

View Full Disclosure